Related Experiment Video
Updated: Jul 8, 2026

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
Translocation pathways for inhaled asbestos fibers
G Miserocchi1, G Sancini, F Mantegazza
1Department of Experimental Medicine, University of Milano-Bicocca, Via Cadore 48, 20052, Monza, Italy. giuseppe.miserocchi@unimib.it
Inhaled asbestos fibers translocate throughout the body via lung fluid dynamics, reaching organs like the kidney and liver. This slow, decades-long process depends on fiber properties and inflammation, impacting asbestos-related disease risk.
Area of Science:
- Pulmonary Medicine
- Toxicology
- Biophysics
Background:
- Inhaled asbestos fibers can translocate from the lungs to other organs.
- Understanding the mechanisms of fiber translocation is crucial for assessing asbestos-related health risks.
Purpose of the Study:
- To elucidate the dynamics of asbestos fiber translocation within the body.
- To investigate the role of pulmonary and pleuro-pulmonary interstitial fluid dynamics in fiber distribution.
Main Methods:
- Analysis of fluid dynamics in the lung interstitium and pleural space.
- Examination of fiber transport via lymphatic and blood systems.
- Correlation of fiber concentration in organs with physiological parameters.
Main Results:
- Asbestos fibers cross the alveolar barrier via paracellular routes driven by osmotic and hydraulic gradients.
- Pulmonary lymph flow facilitates primary translocation to the bloodstream, enabling secondary, whole-body distribution.
- Fiber concentration in organs like the kidney and liver is influenced by perfusion pressure, flow, and microvascular permeability.
Conclusions:
- Asbestos fiber translocation is a slow, multi-decade process influenced by fiber biopersistence, inflammation, and fluid dynamics.
- Ultrafine fibers exhibit greater translocation potential due to reduced steric hindrance.
- Organ-specific fiber accumulation patterns reflect underlying physiological conditions and fluid dynamics.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
